For CAH 17-OHP, androstenedione and 21-DOCL are determined to confirm the diagnosis, and sodium, potassium and plasma renin activity will be analyzed in serum to assess salt-wasting [20]. This evidence concerns the gene REN and congenital adrenal hyperplasia.